Free Trial

Carmell (CTCX) Competitors

Carmell logo
$0.22 0.00 (-0.77%)
(As of 12/20/2024 05:40 PM ET)

CTCX vs. NRXS, MBOT, NEPH, LUCY, LFWD, IINN, SSKN, MHUA, LYRA, and PYPD

Should you be buying Carmell stock or one of its competitors? The main competitors of Carmell include NeurAxis (NRXS), Microbot Medical (MBOT), Nephros (NEPH), Innovative Eyewear (LUCY), ReWalk Robotics (LFWD), Inspira Technologies Oxy B.H.N. (IINN), STRATA Skin Sciences (SSKN), Meihua International Medical Technologies (MHUA), Lyra Therapeutics (LYRA), and PolyPid (PYPD). These companies are all part of the "medical equipment" industry.

Carmell vs.

NeurAxis (NASDAQ:NRXS) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, dividends, profitability, valuation, earnings, community ranking, risk and institutional ownership.

11.8% of NeurAxis shares are held by institutional investors. Comparatively, 24.2% of Carmell shares are held by institutional investors. 15.2% of NeurAxis shares are held by insiders. Comparatively, 29.0% of Carmell shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

NeurAxis has a beta of 4.15, indicating that its share price is 315% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500.

NeurAxis received 1 more outperform votes than Carmell when rated by MarketBeat users.

CompanyUnderperformOutperform
NeurAxisOutperform Votes
1
100.00%
Underperform Votes
No Votes
CarmellN/AN/A

In the previous week, Carmell had 1 more articles in the media than NeurAxis. MarketBeat recorded 1 mentions for Carmell and 0 mentions for NeurAxis. Carmell's average media sentiment score of 0.67 beat NeurAxis' score of 0.00 indicating that Carmell is being referred to more favorably in the news media.

Company Overall Sentiment
NeurAxis Neutral
Carmell Positive

Carmell has a net margin of 0.00% compared to NeurAxis' net margin of -492.76%. NeurAxis' return on equity of 0.00% beat Carmell's return on equity.

Company Net Margins Return on Equity Return on Assets
NeurAxis-492.76% N/A -641.25%
Carmell N/A -217.50%-50.22%

NeurAxis has higher revenue and earnings than Carmell.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeurAxis$2.46M6.82-$14.63M-$1.84-1.30
Carmell$32.84K140.30-$15.44MN/AN/A

Summary

Carmell beats NeurAxis on 7 of the 12 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTCX vs. The Competition

MetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$4.64M$4.34B$5.14B$9.08B
Dividend YieldN/A44.57%5.09%4.23%
P/E RatioN/A25.0189.7417.16
Price / Sales140.3045.901,117.09117.04
Price / CashN/A43.4443.1037.86
Price / Book0.217.094.784.78
Net Income-$15.44M$13.64M$120.31M$225.60M
7 Day Performance4.95%-2.93%-1.92%-1.23%
1 Month Performance-10.22%-1.42%13.65%0.46%
1 Year Performance-94.71%39.20%28.34%15.24%

Carmell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTCX
Carmell
1.2693 of 5 stars
$0.22
-0.8%
N/A-94.5%$4.64M$32,839.000.0014News Coverage
Positive News
NRXS
NeurAxis
N/A$2.51
+1.2%
N/A+5.3%$17.52M$2.46M-1.3519Gap Down
High Trading Volume
MBOT
Microbot Medical
1.9092 of 5 stars
$1.00
flat
$7.00
+600.0%
-29.2%$16.93MN/A-1.2520
NEPH
Nephros
1.6901 of 5 stars
$1.55
flat
$5.00
+222.6%
-47.6%$16.34M$13.55M-17.2230Positive News
LUCY
Innovative Eyewear
1.7076 of 5 stars
$6.52
+6.7%
$20.00
+206.7%
-32.6%$15.92M$1.56M-0.669
LFWD
ReWalk Robotics
3.3589 of 5 stars
$1.63
-1.2%
$13.00
+697.5%
N/A$14.36M$25.00M-0.6260Positive News
High Trading Volume
IINN
Inspira Technologies Oxy B.H.N.
0.3107 of 5 stars
$1.12
-4.3%
N/A-21.9%$14.14MN/A0.0020
SSKN
STRATA Skin Sciences
1.0225 of 5 stars
$2.99
-0.3%
N/A-51.5%$12.47M$32.68M-1.11120Positive News
MHUA
Meihua International Medical Technologies
0.6856 of 5 stars
$0.49
-1.5%
N/A-86.4%$12.38M$94.25M0.00620Gap Down
LYRA
Lyra Therapeutics
2.4053 of 5 stars
$0.19
+1.6%
$4.50
+2,324.6%
-96.1%$12.15M$1.47M-0.1250Gap Down
PYPD
PolyPid
2.3304 of 5 stars
$2.43
-6.9%
$12.00
+393.8%
-17.6%$11.66MN/A-0.3080Analyst Revision
High Trading Volume

Related Companies and Tools


This page (NASDAQ:CTCX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners